Background. Micronutrient interventions are contributing to substantial reductions in global morbidity and mortality. As the diversity and coverage of these interventions expand, it is increasingly important to understand their distinct roles and contributions, and the resources they require. To date, comparing program resource use has been hampered by several noncomparabilities in cost studies relating to diverse intervention activities and service delivery pathways, along with differences in methodological approaches.
Introduction
Micronutrient deficiencies constitute an enormous global public health burden. Deficiencies of just three essential micronutrients-vitamin A, iron, and zincare estimated to result in an annual loss of 1.5 million lives and more than 51 million disability-adjusted life years (DALYs) [1] .
There is an arsenal of interventions with demonstrated effectiveness in combating these deficiencies [2, 3] , and substantial progress has been made [4] [5] [6] . A few high-visibility books and papers on nutrition policy have called for "repositioning nutrition as central to development" [4] , labeled nutrition-and particularly child and maternal nutrition-as "a survival and development priority" [6] , and even estimated the costs of "scaling up nutrition" [7] . Yet inadequate attention has been paid to the issues related to planning or managing nutrition interventions as a portfolio of programs, explicitly and deliberately taking into account their potential overlap, their potential complementarities, or their differences in cost and cost-effectiveness.
Micronutrient supplementation and commercial food fortification are the current leading strategies for addressing micronutrient malnutrition; however, they both demonstrate weaknesses in their delivery, for example, in terms of the ability of industrially fortified foods to adequately reach rural or remote populations in some countries, or the ongoing expenditures required for distribution of supplements [8] [9] [10] . Biofortification is an emerging strategy with strong potential for sustainable benefits. Among subpopulations with high micronutrient requirements, however (such as pregnant women and young children), its role is likely to be relatively limited by two considerations: the ability to fully eliminate the nutrient gap through consumption of staple foods [9, 10] , and the amount of time that it will likely require before this strategy has adequate coverage and impact [11] . These considerations suggest that biofortification will probably be foremost a complementary strategy.
A relatively new debate is whether these micronutrient interventions could complement one another as an integrated portfolio. In such a scenario, supplementation would be provided for severe deficiency, or as an emergency response, while fortification and biofortification interventions would contribute to maintaining adequate micronutrient status and reducing moderate deficiency [9, 10, 12] . The optimal mix of interventions would probably vary to some extent by season, country context, and even among regions and population groups within a country [8, 10, 13] .
The successful reduction in the global burden of disease attributable to micronutrient deficiencies suggests that micronutrient interventions are contributing to substantial global improvements in morbidity and mortality [14] . Given this progress, the need has never been greater for a portfolio approach to fine-tune the programs addressing micronutrient deficiencies. Currently interventions are managed on an ad hoc basis, with no connection between different programs addressing different micronutrient deficiencies, and with implementation falling under the ambit of different government agencies. Considering this lack of coordination, it is likely that there is already considerable overlap among programs, including possibly unexploited economies of scale and/or scope. As the diversity and coverage of these programs expand, it is increasingly important to understand their relative contributions to reducing micronutrient deficiencies. This involves making comparisons across programs; however, to date, the existing data on costs of micronutrient interventions are plagued by noncomparabilities. These relate both to the diverse activities and service delivery pathways of the interventions themselves and to differences among studies in the methods used.
Differences among micronutrient interventions
Part of the challenge in documenting and comparing micronutrient programs, particularly in terms of effectiveness and cost-effectiveness, is the vast differences in types of intervention, in terms of outcomes, target populations, coverage, service delivery pathways, implementing partners, and cost structures, among others. These differences exist even within a particular intervention type. For example, supplementation programs distributing vitamin A to children under 5 years of age are typically able to piggy-back on immunization and other integrated child health campaigns to some extent [15, 16] , achieving substantial coverage rates, minimizing organizational and administrative requirements, and keeping costs relatively low [17] [18] [19] . Meanwhile, distribution of iron supplements to pregnant women commonly has been achieved through routine prenatal care services. Although the coverage of these services is commonly around 70% to 85% of pregnant women, the proportion of these women who receive and take adequate quantities of iron and folic acid tablets is likely to be less than 10% [20] .
Food fortification is another increasingly prevalent mechanism for distributing micronutrients. As of mid-2013, 77 countries were fortifying some or all of their wheat flour with iron and/or folic acid, and in many instances with other nutrients [21] . Other key food vehicles, such as vegetable oil, maize flour, and sugar, are also increasingly being fortified [22] [23] [24] . Fortification commonly involves a partnership between public and private agencies, promoted via either private sector advertisements or government social marketing, and with consumers paying for the commodity through private markets. Whereas mass fortification is targeted at the general population, there are probably particular groups of vulnerable or geographically remote people who consume limited amounts of these foods.
Developing micronutrient-dense staple crops through biofortification is an emerging option for preventing micronutrient deficiencies. Unlike supplementation and commercial fortification, biofortification is a food-based intervention implemented primarily in rural areas and disseminated to consumers through market channels [9, 10, 13] . After significant initial investment in agricultural research and development, biofortification carries minimal recurrent costs and can potentially achieve high coverage, particularly in remote rural areas where both subsistence agriculture and undernutrition predominate; therefore, this strategy is anticipated to be highly cost-effective [25] . However, there are gaps in understanding the actual attributable impact and cost-effectiveness of these projects, since they are still under development and will not be widely adopted for several years [9, 10, 13] . Ex ante analyses indicate that the effectiveness and costeffectiveness of biofortified crops in reducing micronutrient malnutrition will be context-dependent [11, 25] .
Despite the importance of these specificities and distinctions between different intervention types, and their significant implications for planning, implementation, impact, and cost, they are rarely considered in general policy discussions of the costs of micronutrient programs.
Differences in methodology of costing studies
Even if it is assumed that the key characteristics of micronutrient interventions and the characteristics of the countries in which they are implemented are held constant, there may still be marked variations in a program's estimated costs. This is evident when the results of two studies of the Philippines National Vitamin A Supplementation Program are compared. One study estimated the cost to provide one personyear of protection to be US$0.28 [26] , while the other estimated it to be US$339 [27] . Although the program's costs were measured in different years-1993 and 1996, respectively-that alone cannot explain variations of this order of magnitude. In this instance, much of the discrepancy was attributable to how the program was defined, which in turn was due to the different policy issues being addressed. Further, the longstanding reliance on, and continued citing of, a relatively small number of cost studies have created an illusion that there are a large number of recent studies.
Objectives of this review
This paper reviews the micronutrient cost literature, building on previous reviews [28, 29] and focusing on differences among cost studies that limit comparability. The review was undertaken to inform the costing methods for the Micronutrient Program Portfolio Study conducted by HarvestPlus. This study, funded by the Bill & Melinda Gates Foundation, aimed to assess the "optimal" micronutrient program portfolio mix in different countries, in terms of costs, coverage, and cost-effectiveness of three specific intervention types: supplementation, fortification, and biofortification. In designing these portfolio studies, it was considered important to accurately estimate the costs of these interventions in order to inform the efficient allocation of resources and financial requirements to scale up national strategies. Although this review was conducted to inform a specific study, the results are useful to researchers conducting costing studies of these three intervention types who wish to understand the implications of various methodological choices for comparability of findings.
The primary objective of this review was to improve information for decisions about resource allocation by contributing to better understanding of the variations in costs and cost structures of micronutrient interventions. While previous reviews [28, 29] have identified the importance of intervention characteristics and country context in influencing the cost estimates reported in micronutrient cost studies, this review explores these concepts in more detail, paying particular attention to methodological differences among studies. Then the review focuses on three broad methodological considerations that largely shape the process by which a study is conducted: the sources of data used, the definition of cost centers, and several specific methodological choices that significantly influence cost estimates. The review concludes with a summary of implications and recommendations for standardizing future costing studies of micronutrient interventions.
Methods
This review includes papers from both the published and the gray literature on micronutrient supplementation, fortification, and biofortification, covering three essential micronutrients: vitamin A, iron, and zinc. The discussion focuses on what have been the more studied interventions: vitamin A supplementation and fortification. In addition, the relatively limited and necessarily prospective (or ex ante) analyses of biofortification programs were reviewed. Other micronutrient interventions were not included, as these were not a focus of the study for which this review was conducted.
Studies were selected for review based on the availability of empirical data or secondary analysis (n = 130). A list of the key studies reviewed is provided in the Appendix.
For the purposes of this review, a "study" was considered to be a cost analysis of one intervention; reports or articles including cost analyses for multiple interventions (or multiple food vehicles in the case of fortification programs) were considered multiple "studies. " This review is primarily focused on studies conducted since 1995, in addition to two publications that many of these studies cite [30, 31] , along with the earlier core studies on which these publications were based.
More than 80% of the studies were "national" in scope, in that they analyzed interventions that were uniformly implemented throughout a country. For the purposes of this paper, and based on the lack of coverage data, the definition of a program's scope is independent of its level of coverage and is based exclusively on supply-side, structural considerations.
The biofortification cost review is based only upon the HarvestPlus phase I biofortification cost studies of 14 country-crop combinations of high-micronutrientcontent varieties [25] . The discussion was limited to these studies, because the purpose of this review was to provide insights into how best to update the analysis of these same projects using methods enabling comparison with supplementation and fortification programs. These studies include only conventionally bred varieties of cassava, maize, sweet potato, beans, rice, and wheat; no genetically modified crops were included.
To date, the costs of biofortification interventions from ex ante analyses are presented in aggregate, and include the costs of developing this nascent technology. This means that the costs of biofortification are not directly comparable with the costs of supplementation and fortification, and that the specific costs and costing methods of biofortification interventions are something of a black box. Therefore, much of the discussion of noncomparabilities of these studies does not include a discussion of specific costs.
Finally, the sources of variation in cost estimates outlined in this review are not meant to be exhaustive. Other topics also warranting discussion were not addressed here because they are regarded as technical issues for cost analysis in general that are not specifically related to micronutrient interventions.
Findings: Sources of cost variations
The cost literature varies significantly in terms of what costs are included in the analysis. This primarily reflects differences in the interventions and country context, in the objectives of the studies, and how study domains are defined. There are also a variety of ways in which variations in specific costing methodologies result in variations in the estimated cost of a micronutrient program.
Intervention characteristics
The fundamental structure and technology of program implementation strongly influence program costs. The review found that while 70% of vitamin A supplementation program costs are attributable to service delivery personnel, the predominant cost of fortification programs-77% of total program costs on average-is for the fortificant itself. Moreover, among fortification and supplementation programs themselves there is significant heterogeneity. For instance, the integrated child health services package that delivers vitamin A supplements in Zambia, Child Health Week, targets 6-to 59-month-olds and lasts 7 days, whereas the Uganda program, Child Days Plus, targets infants and children from 6 months to 14 years of age and lasts a full month [18, 19] .
Even for supplementation programs implemented within the same country, the cost per person reached can vary substantially, as was found, for example, in Peru, where vitamin A supplementation cost US$1.62 (in 1998 dollars) per person when it was integrated with routine Expanded Program on Immunization (EPI) services and US$2.97 per person when it was distributed through a stand-alone campaign [32] . A study of Ethiopia's Extended Outreach Strategy found that the estimated stand-alone costs of vitamin A capsule distribution were considerably greater than the costs when the distribution was added to an integrated package of campaign-delivered child health services that included deworming, nutrition screening, measles immunization, and Information Education and Communication (IEC) [33] . Integrated child health packages have also been found to enjoy economies of scope in studies of Zambia's Child Health Week and Uganda's Child Days Plus [18, 19] .
There are few cost studies on iron supplementation programs. Iron supplements should be taken with a greater frequency than vitamin A supplements; these interventions therefore require a different implementation mechanism providing many more contacts than the twice-annual vitamin A programs. They are therefore not amenable to being implemented exclusively through efforts piggy-backed on National Immunization Days or Child Health Weeks. Moreover, the much greater frequency of doses means that compliance will be a more important issue (because individuals will self-administer the supplements, whereas vitamin A is usually administered by or in the presence of health professionals), as will a functioning supply chain. These concerns about compliance and frequency of dosage suggest that, compared with vitamin A programs, the costs of iron supplementation are likely to be higher, due mainly to the follow-up required for reaching pregnant women and ensuring compliance. How much more expensive they might be depends upon logistics systems requirements, delivery mechanisms, the size and composition of the target population, and the intensity of efforts for IEC and promotion of compliance, among other considerations.
The cost of fortification programs may also vary substantially due to differences in fortificant type and composition and the level of fortification. Variations in fortificant composition can increase the costs of wheat flour fortification by a factor of nine [29] . Given the high proportion of total fortification costs that is accounted for by the cost of fortificants, increases in fortification levels will produce nearly proportionate increases in the average total cost per metric ton and in the total cost of fortification programs.
Fiedler and Macdonald [34] examined the impact on costs of two different flour fortification packages. The less extensive and less costly one, labeled the "reduced package, " consisted of iron, folic acid, and vitamin B 12 . The "expanded package" consisted of these same three micronutrients in addition to zinc and vitamins B 1 , B 2 , B 3 , B 6 , and A. The expanded fortification package cost approximately twice as much per ton of food as the reduced package in any given country.
The type of fortificant used also accounts for differences in fortification costs. In the case of iron, ferrous fumarate is often used. However, the bioavailability of ferrous fumarate is compromised in countries with diets high in phytates. Sodium iron ethylenediaminetetraacetate (NaFeEDTA), a commonly used and more bioavailable form of iron, costs roughly 20% more [35] .* Even the cost of the same fortificant formulation can * Recommending use of more costly fortificants raises concerns from private industry; this has been a key stumbling block to introducing fortification. To effectively discuss prospects for fortification with industry representatives, it is essential to have greater specificity about costs. vary within a country. A Kenyan study of three maize millers found that prices of the identical maize flour formulation varied by 50% and resulted in differences in the incremental cost per metric ton of nearly onethird [36] .
Costs also vary considerably by food vehicle. A Ugandan study found that while the same percentage of the population ate commercially produced sugar and vegetable oil, vitamin A fortification of sugar would cost the private sector US$2.6 million per year, 4.8 times more than vitamin A fortification of oil would cost the oil industry [37] . Most of this difference in cost was attributable to the different vitamin A compounds used to fortify these foods. Moreover, Fiedler and Macdonald [34] found that for each of the three most common food vehicles (wheat flour, sugar, and vegetable oil), the cost per ton of fortified food was inversely related to plant size, being highest in the smallest plants and lowest in the largest plants. For example, the incremental cost of vitamin A fortification per metric ton of food for an average large-sized flour plant was 57% of the cost for a small-sized plant.
Country context
The cost of any given type of micronutrient supplementation program is also likely to reflect a number of country-specific factors. For example, the relationship between supplementation program coverage and costs reflects a number of characteristics of the healthcare delivery system, including the composition, size, and distribution of its infrastructure. In countries with high population densities, economies of scale may yield a low unit cost per beneficiary. Depending on country population characteristics and distribution, achieving adequate coverage to impact child mortality will typically require expanding into increasingly remote populations, and the marginal costs per beneficiary may become prohibitive [38] . As Horton [39] notes, in countries such as Bangladesh and Cambodia and in parts of India, Pakistan, Laos, and Nepal, where the health infrastructure is less developed-or in the extreme case, where there is no functional health system-the costs of supplementation per beneficiary are likely to be significantly higher.
Further, demand-side factors, such as a population's knowledge of and access to programs, can affect the denominator of the cost measure (i.e., the cost per beneficiary) and may be a key reason for variations across studies [29] .
In one review, country-specific variables were found to influence cost per death and DALY averted of vitamin A supplementation programs, including program coverage, the number of doses delivered, and the underlying level of mortality [17] . Estimates of mortality reduction resulting from vitamin A supplementation in countries with high prevalence rates of vitamin A deficiency ranged from 23% to 30%. A higher reduction in mortality results in a lower estimated cost per death averted and per DALY averted. The mortality reductions, however, were also conditional upon minimal levels of coverage of the program being achieved, with estimated coverage ranging from 70% to 85% (again in "high"-prevalence countries) being essential in order to capture the full impact on mortality. Downplaying or ignoring this conditionality, or assuming the rate of coverage is high, reduces the level of estimated cost-impact measures, making vitamin A supplementation programs a more attractive investment.
Several studies have captured country-level cost variations in different ways, including accounting for differences in population density and transportation costs [27, 40, 41] . A study in Nepal developed separate estimates for mountain, terai (lowland), and hill districts and found the costs of supplementation for these three regions to vary by as much as 43% [40, 41] . A study in South Africa accounted for intracountry cost differences by using state-specific Ministry of Health coverage measures in calculating cost outcomes [42] . As a result, the estimated coverage of the supplementation program varied across states from 58% to 88%, with a national average of 74%. State-level cost estimates are valuable and relevant for state-specific programming and budgeting in decentralized public health systems.
Given the high proportion of supplementation program costs represented by personnel, a country's labor capacity and wages are an important determinant of program costs. Countries in which the major program-implementing agency-usually the Ministry of Health-has especially low salaries will have lower than "average" costs. As such, cost estimates coming from these programs may be artificially low and misleading for budgeting in other country contexts. One study found the average healthcare worker's salary in Ethiopia (US$600) to be only 22% of the sub-Saharan Africa regional average [33] . Using the cost estimates from Ethiopia would significantly underestimate the costs of a comparable program in another country.
There are several country-specific factors that influence fortification program costs. These include food consumption patterns, particularly relative consumption of purchased food compared with own production; industrial structure, including import duties on fortificants, and processing and distribution systems; and the cost of government monitoring and regulation of industry [28, 29] . In many studies, the costs of government regulation are ignored, thus resulting in underestimation of the costs of fortification compared with alternative interventions.
Data sources
The source of data, for measures both of program costs and of effectiveness, determines to a large extent the methodology used in a study.
Cost data
Two common sources of cost data are a program's accounting records and estimates developed with an "ingredients approach" using unit costs and quantities of program inputs [43] .
The accounting-based approach is limited by the comprehensiveness of the accounting system, and there is often a need to augment the cost-accounting data with additional information to capture all resources. Resources that are unlikely to be recorded in a program's financial accounting systems include in-kind contributions, such as micronutrient supplements or fortificants donated by private or international agencies. Other examples of "off-budget" costs include resources shared among programs, resources contributed by partner organizations, and opportunity costs of capital, personnel, and program beneficiaries. Opportunity costs can represent a significant proportion of total program resource use, particularly for programs relying on volunteer labor. A study in the Philippines estimated that 30% of the costs of a vitamin A supplementation program were attributable to volunteer labor [27] . Studies excluding an estimate of these economic costs may therefore report artificially low cost estimates, which could mislead other countries planning to implement similar programs.
While the accounting approach could be considered a top-down methodology using existing data to build cost estimates, the ingredients approach is a bottomup methodology relying primarily on data obtained from interviews to identify all inputs used to produce a particular output. The ingredients approach provides a mechanism for standardizing common program components across countries, thereby enabling crosscountry and interregional comparisons, and provides opportunities for identifying how the relationships between inputs and outputs may be modified to reduce costs, increase outputs, or both. In the ingredients approach, the cost analysis is built up from the sum of its parts, using costing algorithms with the cost and quantity of various program inputs to produce transparent estimates. This method was used in an analysis of Ethiopia's Enhanced Outreach Strategy, to develop regional unit costs at different administrative levels, providing insights into the extent of interregional cost variation [33] .
When building cost estimates from scratch, surveys are a useful tool for developing a detailed understanding of how a program functions and how its performance and costs vary across the different levels of the implementing organization. However, survey data are not always used for better understanding programs. For instance, three connected vitamin A supplementation program studies in Ghana, Zambia, and Tanzania were based on nationally representative district-level survey samples; however, the studies then simply developed a national average based on that sample [44] [45] [46] . The opportunity was lost to better understand how costs were affected by variations in urban-rural population ratios, population density, ecology, topography, or accessibility, and the potential was not fully realized for developing cost estimates that could provide a more accurate tool for allocating program resources. Some common practices compromising the potential level of precision of cost estimates attained from survey data related to the way in which surveys were structured, how the sample was identified, how the data were analyzed, and how the cost estimates based on them were extrapolated to the country level.
Effectiveness data
The large variety of cost outcomes reported in the micronutrient intervention cost studies can themselves contribute to noncomparabilities. "Cost outcomes" are a common way to present the results of an economic analysis, often calculated as cost per program outcome or impact. Studies lacking data on program effectiveness often present the total program cost or the cost per beneficiary [29] .
Supplementation programs commonly report the cost per beneficiary. When coverage data are not available, data may be used from Demographic and Health Surveys, such as the proportion of children whose mothers reported the child received a vitamin A supplement in the past 6 months. Two other common approaches using program data are the number of persons dosed, as reported in tally sheets maintained by the service delivery staff; or a proxy measure, such as the number of capsules (or tablets or doses of syrup) distributed. These per capita measures often vary depending on whether the data come from programbased or population-based surveys, with program data reporting substantially higher coverage rates [47, 48] .
This variation also relates to the nature of the implementing agency, since nongovernmental organizations (NGOs) may rely on program data while governments may rely more on population-based surveys. Cost studies from NGO programs yield costs per beneficiary that are between one-quarter and one-third higher than those for public sector programs [28, 29] . In addition to possible differences in methods and contextual factors, this higher cost may reflect the facts that NGOs may have better-paid staff, serve more remote areas, or have more comprehensive documentation of program inputs.
Fortification programs commonly report the incremental cost per metric ton of the food vehicle, the proportion of the increase in a the retail price of a food due to its fortification, and the cost per person per year [28, 29] . Because of the limited availability of individual food consumption data, most fortification study cost measures are devoid of program impact denominators, relying instead on unconditional national per capita consumption data. This practice renders them subject to even greater uncertainty than supplementation program measures, in terms of their validity and reliability in measuring changes in micronutrient status. Food consumption and household expenditure surveys have been used to measure individual-specific fortification impacts in only two countries-South Africa and the Philippines [27, 49] -to estimate the cost per micronutrient-deficient person reached and the cost per micronutrient-deficient person whose deficiency is eliminated by fortification. Recent methodological advances have used Household Consumption and Expenditure Survey (HCES) data, combining the quantity of different food types "apparently consumed" with the nutrient contents of the foods to estimate conditional consumption levels, to model usual intake, deficiencies, and impacts of proposed programs [50] (personal communication, Z. Rambeloson, monitoring and evaluation expert of A2Z, the USAID Micronutrient Project, 2010). This is an area requiring further investigation to improve understanding and measurement of the impact and costs of fortification and biofortification programs.
Other common effectiveness measures that are found in the micronutrient program cost literature are the cost per life saved (death averted) and cost per DALY saved. Several methodologies have been used to estimate the impact of vitamin A supplementation programs in terms of lives or DALYs saved, usually involving assumptions about mortality reductions achievable given different coverage rates [51] [52] [53] .* As discussed previously, assumptions about the number of deaths averted strongly affect the number of DALYs saved and therefore the cost per DALY. The 2010 update of the Global Burden of Disease (GBD) study demonstrated significant gains in life expectancy, with deaths among children under 5 years of age declining by nearly 60% since 1970 [54] . The 2013 Lancet Series on Maternal and Child Nutrition did not use the updated GBD estimates [55] . Their estimates of deaths attributable to micronutrient deficiencies were lower than the estimates in the previous 2008 Series, but higher than those in the 2010 GBD update. The authors postulated that this reduction in mortality was due in part to the effectiveness of large-scale supplementation programs, along with general improvement in nutritional status and treatment of illness. The changes in underlying mortality risks will impact future cost estimates of micronutrient programs, and by decreasing the denominator of cost measures, will necessarily *UNICEF. Note for the record: Calculation of the number of lives saved with vitamin A supplementation. Unpublished memorandum and Excel spreadsheet. New York: UNICEF, 2001. show a decrease in the relative cost-effectiveness of these programs.
Definition of cost centers
One of the first steps in undertaking a cost analysis is to define the study's "cost centers, " which organize and categorize the resources used in a program. How they are defined is both influenced by, and influences, the choice of methodology used in the study, particularly the data source. The two most common sources of cost data, discussed previously, also characterize the two most common ways of categorizing costs, namely the cost accounting-based approach and the ingredients approach.
Cost centers in the cost accounting-based approach are generally defined in a manner identical to the implementing agency's existing cost accounting system, in terms of the inputs (objects of expenditure) tracked within that system. These include personnel, pharmaceutical supplies, medical supplies, office supplies, equipment, basic services, etc.
Unit costs estimated with the ingredients approach can be classified in a variety of ways, including by input category, intervention activity, or organizational level [43] . Several studies have combined an ingredients approach with an activity-based costing (ABC) methodology [18, 19, 27] , wherein algorithms are specified for all major program activities. These algorithms are useful for planning and budgeting and can be used dynamically to envision the cost of program scale-up.
Biofortification program cost structures
The costs of biofortification can be broken down into several distinct cost centers; the categories selected influence the scope of costs included in the analysis, with implications for cost levels. The full life cycle of a biofortified crop can be conceptualized as consisting of four distinct, but overlapping, phases: Basic research and development (R&D), during which several promising parent lines are developed that are used to produce lines for several countries; Adaptive breeding of the parent line to better provide for the individual country's needs; Release and dissemination, consisting of the incremental costs for seed systems to release, multiply, and distribute the biofortified variety, nutrition education, and behavior change communication; and Maintenance breeding to ensure that the enhanced micronutrient and agronomic characteristics of the biofortified hybrid are maintained over time.
The average share of each of the four components has varied from 17% for maintenance breeding, to 22% for R&D, 25% for adaptive breeding, and 35% for release and dissemination. The costs of each of the four components of the biofortification projects vary substantially, with those for release and dissemination having by far the largest variance. The lowest-cost release and dissemination effort was that of the highiron and high-zinc beans project in Honduras, which was estimated to cost US$328,000, compared with the provitamin A cassava project of Nigeria, which was estimated at more than US$21 million, nearly 70 times larger.
Inclusion of R&D costs in program cost estimates is somewhat controversial in that these costs may be conceptualized as occurring prior to implementation. This would complicate comparisons with other interventions that have been developed and are ready to be introduced or scaled up. However, simple exclusion of R&D costs does not necessarily promote comparisons with other interventions, due to the need for adaptive breeding that fits country-specific contexts and regulations.
In the studies reviewed, the methods used to estimate these costs varied by component. The R&D costs were based on historical R&D estimates from crop-specific budgets. The other three components, comprising 78% of total costs, were based on country-and crop-specific expert opinion. While the general comparability of the methodologies that these 14 different individuals used to develop the estimates is unknown, there is considerable room for variation, making direct comparisons difficult.
As with fortification and supplementation programs, there are multiple potential sources of variation in the level and composition of costs across the biofortification cost studies. These include variations in country-specific characteristics, such as the prices of nontradable inputs like researchers' salaries and media, the size of the populations they might be expected to reach (both of consumers and of farmers), and the nature of the nutrition education and behavior change communication in the dissemination component.
Choice of methodology and differences among methods
This section summarizes several methodological choices that have had implications for the cost levels and outcomes reported in the micronutrient cost literature.
Analytical perspective: Whose costs to include
Depending on its objectives, an analysis can be conducted from the perspective of implementing institutions or it can provide more comprehensive estimates of the costs to society as a whole [56] . Study objectives and perspectives influence which costs are appropriate to include.
The analytical perspective is likely to vary by intervention type, study objective, and how the domain of the costing study is defined. Fortification studies commonly include costs to private industry, whereas supplementation studies include costs to government. It is much less common for studies to take a societal perspective. However, assessing broader program costs, including the costs to program participants, can provide insight into potential users' ease of participating in a program, which affects program participation and coverage, and thereby the average cost per beneficiary.
Many of the costs of supplementation programs in particular are relatively fixed (i.e., they do not change or do not change in direct proportion to the increase in output or persons served); therefore, increasing program participation rates generally means decreasing the program's average cost per beneficiary. However, whether a program has a low cost per beneficiary may change when costs incurred by beneficiary households themselves are included. Existing supplementation studies investigating household costs have found them to range widely from 79% of an iron program's total costs to 65% of a vitamin A program's total costs, down to 18% of the total costs of a facility-based strategy to prevent malaria and anemia [57] [58] [59] .
Cost studies of fortification programs vary significantly in the methods used and the type of costs included in the estimates, with private industry costs estimated more precisely than government costs [28, 29] . There are several reasons for the differential rates of precision in the studies reviewed. First, the costs of the government components of programs-constructing the policy environment, marketing and education efforts, quality assurance monitoring, and nutrition surveillance-are likely to be subject to considerable variation because they commonly reflect anticipated budgetary allocations. Second, some countries only added to the responsibilities of their existing agencies, whereas other countries needed to establish such agencies "from scratch. " Thus, the costs of marketing and education vary from 1% in the Indonesian and Pakistani wheat flour fortification proposals to 14% in the cases of China and Thailand [60] . Lastly, private industry representatives were motivated to provide accurate estimates for costing exercises to avoid putting their industries at financial risk by the cost estimates if their respective governments opted to implement these programs.
Price adjustments and price indices
The literature contains a number of different cost measures that require adjustments for analysis. For example, data are not always adjusted for changes in currency value. When the literature is reviewed, the year in which the original study was conducted-as opposed to the year of publication-is often not reported. Given that it generally takes a year or two for studies to be reported or published, and the not uncommon practice of basing studies on program or consumption data that are several years old, variation in the value of the currency is a potential source of significant variation in reported cost results. For instance, the 1987 SCN State of the Art Review used data from an Indonesian vitamin A supplementation program from 1975 [61] , and a 1999 publication of a program study in Tanzania was based on 1992 data [62] .
Further, it is unclear whether adjustments in currency value are properly made. The common practice is to use the consumer price index (CPI) or a gross domestic product (GDP) or gross national product (GNP) deflator, which, depending upon the program's cost structure, may result in substantial over-or underadjustment. A vitamin A study in the Philippines conducted a sensitivity analysis of the use of a GDP deflator, a CPI deflator, and a program-specific adjustment index that was based on changes in the major cost elements of the program [27] . The programspecific adjustment consisted of four components: the imputed wage of volunteers, the average wage increase of Ministry of Health personnel, change in the price of vitamin A capsules owing to the devaluation of Filipino currency, and the remaining 25% of costs adjusted by the CPI. The analysis found that the more circumspect approach resulted in a doubling of the adjustment of the vitamin A supplementation program costs: the estimated increase in costs was 15%, compared with 7% with the use of either the CPI or the GDP deflator. This is a topic that merits more attention, especially given that the costs of micronutrient interventions are so highly concentrated in a few inputs, with personnel and fortificants accounting for a large proportion of the total costs of supplementation and fortification programs, respectively [28, 29] .
Time domain differences
The review contained two distinct types of cost studies: roughly 60% of the studies were "prospective" or "ex ante" studies modeling costs of hypothetical programs, and 40% were "retrospective, " estimating costs of existing programs. The type of study varied by program, with all of the supplementation cost studies being retrospective, the fortification studies being mainly prospective, and the biofortification studies being ex ante, since these technologies have not yet been released. These differences reflect the different motivations for conducting these studies: to promote or raise funds for an existing supplementation program, to provide a detailed accounting to private sector partners of potential fortification programs, or to demonstrate the attractiveness of biofortification programs as social investments.
These different study types result in cost estimates of varying degrees of certainty and precision; therefore, systematic differences in study type across the three micronutrient programs reduce the direct comparability of their cost estimates. Several characteristics of ex ante studies make them particularly likely to generate estimates with greater uncertainty and less precision. First, they are based on assumptions about program implementation. Second, different studies include different costs, depending on whether the technology has been developed (commonly used for fortification programs) or is still undergoing R&D (commonly used for biofortification programs).
Summary of implications and recommendations
This review has shown that there are significant variations in cost estimates of micronutrient interventions and that the sources of these variations are numerous. The content of cost estimates and approaches to calculating them vary depending upon a number of interrelated factors, including: » The specific characteristics of the country » The specific characteristics of the program and how it is implemented » The purpose for which costs are being estimated » Which costs are included in the estimates (private sector, public sector, households) » The audience » The perspective of the analysis (i.e., societal versus institutional) » The study domain (what is included in the cost analysis) » The methodological approach adopted » The time available for carrying out the study » The resources available for undertaking the study » The source(s) of data.
Taking into account the methods used in the studies reviewed for this paper, there are several implications for improving the design of micronutrient cost studies. The following recommendations can be used to ensure that cost estimates are as precise as possible and that the results are as comprehensive and as comparable as possible across interventions within countries as well as across countries: » Calculate the total (economic) cost along with additional budgetary requirements, to allow program managers to better understand resource requirements for budgeting purposes. Since micronutrient programs often piggy-back on existing programs, the important measure for decision makers is the incremental cost that the micronutrient intervention will require, rather than the total costs. Still, so as not to be vulnerable to charges of trying to minimize costs-especially in the case of supplementation programs that are delivered as part of a multiintervention package-it is important to develop the methodology in such a manner as to enable presentation of the incremental costs of the micronutrient supplementation, along with the cost of the micronutrient program component alone, as
if it were a stand-alone intervention. » When comparing interventions, use the same basic costing approach, ensuring that the types of costs compared are the same. » Given that these interventions are commonly piggybacked on other existing programs, some shared program elements should be addressed when developing cost estimates for each of the intervention types: -Identifying and prorating shared resources or inputs:
These are likely to be important, and the appropriate portion of these inputs that are used in the micronutrient intervention should be identified and used to attribute a share of them to the program. -Off-budget items: It is essential to include these to estimate the intervention's "full" or "economic" costs. Given the differential importance of offbudget items by type of micronutrient program, other things being equal, not including them would make supplementation interventions look substantially less costly than they are. » The costs included should be as comprehensive as possible. Where community costs are likely to contribute significantly to total program resource use, a societal perspective should be applied. Although taking the societal perspective provides useful information informing program utilization, it also consumes additional time and resources. Given resource constraints in each specific situation, it is essential to weigh the expected costs and potential benefits that are likely to result from alternative study designs in order to best strike this balance. This requires being cognizant of the full range of program costs from the onset of study design and identifying what are potentially important policy issues that need to be addressed so that budget constraints do not end up undermining the usefulness of the study. » Where applicable, ensure that volunteer labor time is noted and valuated, both to ensure comparability across countries and to better understand implementation, an important source of variation in estimated costs. Ensure that relevant public sector costs are included, especially monitoring and regulatory costs for fortification programs, which are often neglected.
Using cost centers that are composed of the major activities of a program can aid in capturing all program inputs in an analysis. » Much of the variation in costs in the literature is attributable to country-specific characteristics. Therefore, studies that compare program costs within a country are much more likely to be precise than ones making across-country comparisons. Conduct comparative analyses within the same country to enable controlling for as many variables as possible and thereby better ensure the comparability of the costs and other findings. Finally, because costs are so influenced by contextual factors, it is advisable to report a series of metrics and to describe programs and country contexts in much greater detail than is currently the norm. » Given all of the critical assumptions involved in estimating DALYs and how these influence the cost outcomes of a study, it is advisable to present multiple cost outcomes (e.g., cost per outcome, cost per impact, or even cost per beneficiary). This serves at least two purposes. First, it facilitates triangulation with cost per DALY. If an intervention is highly cost-effective per DALY averted, this could be due in part to assumptions of high mortality in untreated cases; if the cost per beneficiary or per case recovered is high, this provides information on the general affordability of the program. Second, although cost per DALY is useful to policy makers for decisionmaking and prioritizing interventions for reduction of morbidity and mortality, this measure does not provide guidance on how many resources (or what kinds of resources) are needed for each beneficiary entering the program. Providing a cost measure per disease outcome (e.g., cost per case of anemia or episode of diarrhea averted) further enables comparison of the intervention with others addressing this same specific outcome. » It essential to carefully develop cost estimates and conduct sensitivity analyses on the costs of key inputs (including micronutrient fortificants or premixes) and other measurements (including annual coverage costs and cost per DALY). Further, both cost analyses and the methods for adjusting costs should be as input-or goods-specific as possible so as to better ensure the accuracy of estimated costs over time. » Undertaking small-scale surveys to collect information is useful to better understand the determinants of costs and thereby variations in costs in order to construct more accurate cost estimates. Developing and implementing a study that allows for this type of variation requires more effort and resources, and whether it is worthwhile depends in part on the study objective and how the results will be used. However, when studies have been designed to allow for variations in cost structures according to the level of the program, they have generally found significant variation.
Conclusions
The methodological variations and noncomparabilities outlined in this review do much more than limit the ability to make direct comparisons of costing studies; they carry important implications for adoption of interventions in countries suffering from deficiencies in key micronutrients. Given the indications of improvement in the global burden of micronutrient deficiencies, it is important to focus on streamlining implementation of these interventions. There is a need to better understand not only which programs should be implemented, where, and when, but also how, in terms of what level of support (both financial and otherwise) they will require to achieve specified levels of coverage and performance. Having comparable and accurate estimates of costs is a necessary first step in creating an integrated portfolio of interventions that are of adequate scale and adequately resourced for effective implementation.
